To determine if PAK1 loss is correlated with any losses in the signaling components identified in our rat L6.GLUT4myc myotube studies, activation and protein levels of p38MAPK, ATF2, and PGC1α were evaluated using the same human non-diabetic and T2D skeletal muscle samples. This evidence concerns the gene PPARGC1A and type 2 diabetes mellitus.